[go: up one dir, main page]

FI20105825A7 - Veriryhmästatuksen käyttö III - Google Patents

Veriryhmästatuksen käyttö III

Info

Publication number
FI20105825A7
FI20105825A7 FI20105825A FI20105825A FI20105825A7 FI 20105825 A7 FI20105825 A7 FI 20105825A7 FI 20105825 A FI20105825 A FI 20105825A FI 20105825 A FI20105825 A FI 20105825A FI 20105825 A7 FI20105825 A7 FI 20105825A7
Authority
FI
Finland
Prior art keywords
secretor
blood group
group status
intestine
individuals
Prior art date
Application number
FI20105825A
Other languages
English (en)
Swedish (sv)
Other versions
FI20105825A0 (fi
Inventor
Pirjo Wacklin
Jaana Maettoe
Harri Maekivuokko
Jukka Partanen
Original Assignee
Suomen Punainen Risti Veripalvelu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suomen Punainen Risti Veripalvelu filed Critical Suomen Punainen Risti Veripalvelu
Priority to FI20105825A priority Critical patent/FI20105825A7/fi
Publication of FI20105825A0 publication Critical patent/FI20105825A0/fi
Priority to US13/812,799 priority patent/US20130195820A1/en
Priority to EP11808883.0A priority patent/EP2598155A2/en
Priority to PCT/FI2011/050674 priority patent/WO2012013861A2/en
Publication of FI20105825A7 publication Critical patent/FI20105825A7/fi
Priority to US14/577,072 priority patent/US20150104423A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI20105825A 2010-07-26 2010-07-26 Veriryhmästatuksen käyttö III FI20105825A7 (fi)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FI20105825A FI20105825A7 (fi) 2010-07-26 2010-07-26 Veriryhmästatuksen käyttö III
US13/812,799 US20130195820A1 (en) 2010-07-26 2011-07-26 Use of blood group status iii
EP11808883.0A EP2598155A2 (en) 2010-07-26 2011-07-26 Use of blood group status iii
PCT/FI2011/050674 WO2012013861A2 (en) 2010-07-26 2011-07-26 Use of blood group status iii
US14/577,072 US20150104423A1 (en) 2010-07-26 2014-12-19 Use of blood group status iii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20105825A FI20105825A7 (fi) 2010-07-26 2010-07-26 Veriryhmästatuksen käyttö III

Publications (2)

Publication Number Publication Date
FI20105825A0 FI20105825A0 (fi) 2010-07-26
FI20105825A7 true FI20105825A7 (fi) 2012-01-27

Family

ID=42555518

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20105825A FI20105825A7 (fi) 2010-07-26 2010-07-26 Veriryhmästatuksen käyttö III

Country Status (2)

Country Link
US (2) US20130195820A1 (fi)
FI (1) FI20105825A7 (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2916399T3 (es) 2010-02-01 2022-06-30 Rebiotix Inc Bacterioterapia para la colitis por Clostridium difficile
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
NZ709392A (en) 2012-11-23 2016-10-28 Seres Therapeutics Inc Synergistic bacterial compositions and methods of production and use thereof
JP2016509003A (ja) 2013-02-04 2016-03-24 セレス セラピューティクス インコーポレイテッド 組成物および方法
AU2014232370B2 (en) 2013-03-15 2018-11-01 Société des Produits Nestlé S.A. Network-based microbial compositions and methods
US9511100B2 (en) 2013-06-05 2016-12-06 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9511099B2 (en) 2013-06-05 2016-12-06 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9694039B2 (en) 2013-06-05 2017-07-04 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US10383901B2 (en) 2013-06-05 2019-08-20 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
AU2014275025B2 (en) 2013-06-05 2016-12-01 Ferring Microbiome Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
US9782445B2 (en) 2013-06-05 2017-10-10 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
DK3074027T3 (da) 2013-11-25 2025-03-17 Nestle Sa Synergistiske bakteriesammensætninger og fremgangsmåder til fremstilling og anvendelse heraf
JP2018515426A (ja) * 2015-03-12 2018-06-14 ザ ユニヴァーシティ オブ ブリティッシュ コロンビア 細菌組成物およびその使用方法
US10799539B2 (en) 2015-06-09 2020-10-13 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
JP6616431B2 (ja) 2015-06-09 2019-12-04 レビオティクス インコーポレイテッド マイクロバイオータ回復治療（ｍｒｔ）組成物の製造方法
US10905726B2 (en) 2015-06-09 2021-02-02 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US10828340B2 (en) 2015-06-09 2020-11-10 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
EP3668527A1 (en) 2017-08-14 2020-06-24 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
EP3703720A1 (en) 2017-10-30 2020-09-09 Seres Therapeutics, Inc. Compositions and methods for treating antibiotic resistance

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9603876B2 (en) * 2008-09-25 2017-03-28 New York University Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment
US20120020941A1 (en) * 2010-07-26 2012-01-26 Suomen Punainen Risti Veripalvelu Use of blood group status iii

Also Published As

Publication number Publication date
US20150104423A1 (en) 2015-04-16
FI20105825A0 (fi) 2010-07-26
US20130195820A1 (en) 2013-08-01

Similar Documents

Publication Publication Date Title
FI20105825A7 (fi) Veriryhmästatuksen käyttö III
WO2012013861A3 (en) Use of blood group status iii
MX2015005944A (es) Cepas microbianas, composiciones y metodos para incrementar el fosfato disponible para las plantas.
NZ709392A (en) Synergistic bacterial compositions and methods of production and use thereof
MX2022012374A (es) Composiciones multi-suplementos.
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
PH12016501512B1 (en) Treatment for resistant acne
PH12015502216A1 (en) Compositions and methods for improving the health of aquatic animals
PH12015502401A1 (en) Compositions and methods for enhancing microbial stability
MX2011007763A (es) Metodos y composiciones para tratamiento de cancer de pulmon.
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
BR112018075900A2 (pt) composições para higiene bucal e métodos de uso
UA108973C2 (uk) Ароматизуюча композиція для зменшення адсорбованого тютюнового запаху і сигарета
MX348325B (es) Composicion que contiene galacto-oligosacarido y un metodo para producirla.
PH12019502469B1 (en) Novel fragrance compositions and products with mood enhancing effects
PH12015501099A1 (en) Synbiotic composition and use thereof
IN2014DN02926A (fi)
ZA201404537B (en) Method and composition for increasing the proportion of dietary ingredients that are resistant to degradation by ruminal microorganisms
PH12014500536A1 (en) Compositions and methods for treating cancer using pi3k beta inhibitor and mapk pathway inhibitor, including mek and raf inhibitors
MX2016006141A (es) Composiciones para barniz dental y metodos para su uso.
MX363385B (es) Métodos para el tratamiento de enfermedad de células falciformes y otras condiciones inflamatorias.
CY1119470T1 (el) Γαλακταγωγες συνθεσεις με βαση φωσφατιδυλοσερινη
MX2015001648A (es) Composiciones que comprenden derivados de espicamicina y metodos de uso de los mismos.
AU2012248013B2 (en) Intermediate for synthesizing caspofungin and preparation method therefor
MX2011010046A (es) Derivados de diaminopteridina.